Rebecca H. Boucher
Birmingham City University(GB)Cancer Research UK Clinical Trials Unit(GB)University of Birmingham(GB)
Publications by Year
Research Areas
Myeloproliferative Neoplasms: Diagnosis and Treatment, Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → In meta-analyses of proportion studies, funnel plots were found to be an inaccurate method of assessing publication bias(2014)761 cited
- → Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study(2019)266 cited
- → Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial(2023)129 cited
- → Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA : a 23‐gene panel with utility for non‐invasive diagnosis and risk stratification(2019)57 cited
- → The STELLAR trial protocol: a prospective multicentre trial for Richter’s syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease(2019)32 cited
- → The poor outcome in high molecular risk, hydroxycarbamide-resistant/intolerant ET is not ameliorated by ruxolitinib(2019)20 cited